• Explore /
  • Poster
  • / Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC).

Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC).

Abstract Poster

Authors

null

Matt D. Galsky

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Matt D. Galsky , Lauren Christine Harshman , Simon J. Crabb , Yu-Ning Wong , Evan Y. Yu , Simon Chowdhury , Thomas Powles , Sumanta Kumar Pal , Erin L. Moshier , Sylvain Ladoire , Syed A. Hussain , Neeraj Agarwal , Ulka N. Vaishampayan , Federica Recine , Dominik Berthold , Andrea Necchi , Christine Theodore , Matthew I. Milowsky , Joaquim Bellmunt , Jonathan E. Rosenberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer

Sub Track

Bladder Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 4512)

DOI

10.1200/jco.2014.32.15_suppl.4512

Abstract #

4512

Poster Bd #

4

Abstract Disclosures

Similar Posters

First Author: Kamaneh Montazeri

First Author: Roland Seiler

First Author: Lauren Christine Harshman

First Author: Srikala S. Sridhar